Shanghai, China

Xudong Qu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xudong Qu. Retrieved from https://idiyas.com/inventor/xudong-qu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xudong Qu: Innovator in Gene Cluster Research

Introduction

Xudong Qu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the area of gene clusters and their applications.

Latest Patents

Xudong Qu holds a patent for a novel isolated DNA sequence that comprises all or part of a gene cluster encoding sanglifehrin synthase. This patent includes processing and regulatory genes involved in the biosynthesis of a mixed non-ribosomal peptide/polyketide compound. The invention also covers mutants with altered biosynthetic capabilities, polypeptides, and vectors containing the DNA. Additionally, it describes host cells transformed with the DNA or vectors, along with a method for producing sanglifehrin compounds. These compounds exhibit cyclophilin inhibition activity, which can be utilized as immunosuppressants, antivirals, or cardiac protection agents. He has 1 patent to his name.

Career Highlights

Xudong Qu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of gene clusters and their potential applications in medicine.

Collaborations

Xudong Qu collaborates with notable colleagues, including Wen Liu and Nan Jiang, who contribute to his research endeavors.

Conclusion

Xudong Qu's innovative work in gene cluster research highlights his role as a key figure in biotechnology. His contributions have the potential to impact various fields, including medicine and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…